marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-14-2023
Navidea Biopharmaceuticals Balance Sheet 2011-2024 | NAVB
Annual Balance Sheet Navidea Biopharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-1.98 M | -3.93 M | -1.33 M | 21.7 K | -2.57 M | -441 K | 60.1 M | 53.9 M | 28.4 M | -5.27 M | 568 K | -22.2 M |
Long Term Debt |
1.31 K | 20.3 K | - | - | - | - | 9.64 M | 60.7 M | 29.5 M | 23.6 M | 6.93 M | 6.46 M |
Long Term Debt Current |
19 K | 276 K | 295 K | 251 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 996 K | 1.21 M | 1.23 M | 665 K | 10.3 M | 62.6 M | 32.6 M | 33 M | 7.19 M | 6.71 M |
Total Current Liabilities |
9.94 M | 5.3 M | 4.72 M | 3.82 M | 3.38 M | 8.07 M | 69.9 M | 6.18 M | 9.1 M | 11.3 M | 6.19 M | 3.35 M |
Total Liabilities |
12.5 M | 6.02 M | 5.71 M | 5.03 M | 4.61 M | 8.73 M | 80.1 M | 68.8 M | 41.7 M | 44.3 M | 13.4 M | 10.1 M |
Deferred Revenue |
800 K | 40.8 K | 700 K | - | 867 K | - | 2.32 M | 1.04 M | - | - | - | - |
Retained Earnings |
-388 M | -371 M | -359 M | -348 M | -337 M | -320 M | -395 M | -381 M | -353 M | -317 M | -275 M | -245 M |
Total Assets |
4.37 M | 6.64 M | 7.76 M | 4.15 M | 7.02 M | 20.8 M | 12.5 M | 15 M | 11.9 M | 40.3 M | 12 M | 31.2 M |
Cash and Cash Equivalents |
2 M | 4.23 M | 2.67 M | 1.05 M | 3.48 M | 2.8 M | 1.54 M | 7.17 M | 5.48 M | 32.9 M | 9.12 M | 28.6 M |
Book Value |
-8.14 M | 625 K | 2.05 M | -881 K | 2.41 M | 12 M | -67.7 M | -53.8 M | -29.8 M | -4.01 M | -1.41 M | 21.1 M |
Total Shareholders Equity |
-8.44 M | -107 K | 1.32 M | -1.61 M | 1.74 M | 11.4 M | -68.1 M | -54.3 M | -29.8 M | -4.01 M | -1.41 M | 21.1 M |
All numbers in USD currency
Quarterly Balance Sheet Navidea Biopharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
269 | 534 | 926 | 1.31 K | 1.69 K | 2.06 K | 11.3 K | 20.3 K | 29 K | 120 K | 209 K | 296 K | 296 K | 296 K | 296 K | 512 K | 512 K | 512 K | 512 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
8.68 M | 9.01 M | 11.9 M | 12.5 M | 10.9 M | 6.74 M | 5.71 M | 6.02 M | 4.83 M | 4.85 M | 5.07 M | 5.71 M | 5.71 M | 5.71 M | 5.71 M | 5.03 M | 5.03 M | 5.03 M | 5.03 M | 4.61 M | 4.61 M | 4.61 M | 4.61 M | 8.73 M | 8.73 M | 8.73 M | 8.73 M | 80.1 M | 80.1 M | 80.1 M | 80.1 M | 68.8 M | 68.8 M | 68.8 M | 68.8 M | 41.6 M | 41.6 M | 41.6 M | 41.7 M | 44.3 M | 44.3 M | 44.3 M | 44.3 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M |
Deferred Revenue |
800 K | 800 K | 800 K | 800 K | 800 K | - | - | - | - | - | - | - | - | - | - | - | - | 495 K | - | - | - | - | - | - | - | - | 15 K | 15 K | 15 K | 682 K | 15 K | 1.04 M | 1.04 M | 1.04 M | 1.04 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 736 K | - |
Retained Earnings |
-386 M | -384 M | -389 M | -388 M | -385 M | -377 M | -374 M | -371 M | -367 M | -365 M | -362 M | -359 M | -359 M | -359 M | -359 M | -348 M | -348 M | -348 M | -348 M | -337 M | -337 M | -337 M | -337 M | -320 M | -320 M | -320 M | -320 M | -395 M | -395 M | -395 M | -395 M | -381 M | -381 M | -381 M | -381 M | -353 M | -353 M | -353 M | -353 M | -317 M | -317 M | -317 M | -317 M | -275 M | -275 M | -275 M | -275 M | -245 M | -245 M | -245 M | -245 M |
Total Assets |
5.7 M | 8.22 M | 2.37 M | 4.37 M | 6.26 M | 2.5 M | 3.6 M | 6.64 M | 8.96 M | 11.3 M | 10.1 M | 7.76 M | 7.76 M | 7.76 M | 7.76 M | 4.15 M | 4.15 M | 4.15 M | 4.15 M | 7.02 M | 7.02 M | 7.02 M | 7.02 M | 20.8 M | 20.8 M | 20.8 M | 20.8 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 15 M | 15 M | 15 M | 15 M | 11.8 M | 11.8 M | 11.8 M | 11.9 M | 40.3 M | 40.3 M | 40.3 M | 40.3 M | 12 M | 12 M | 12 M | 12 M | 31.2 M | 31.2 M | 31.2 M | 31.2 M |
Cash and Cash Equivalents |
3.86 M | 6.14 M | 33.8 K | 2 M | 4.6 M | 328 K | 1.22 M | 4.23 M | 7.18 M | 7.11 M | 7.51 M | 2.67 M | 2.67 M | 2.67 M | 2.67 M | 1.05 M | 1.05 M | 1.05 M | 1.05 M | 3.48 M | 3.48 M | 3.48 M | 3.48 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 1.54 M | 1.54 M | 1.54 M | 5.48 M | 7.17 M | 11.4 M | 15.8 M | 7.17 M | 5.48 M | 5.48 M | 5.48 M | 5.48 M | 32.9 M | 32.9 M | 32.9 M | 32.9 M | 9.12 M | 9.12 M | 9.12 M | 9.12 M | 28.6 M | 28.6 M | 7.54 M | 28.6 M |
Book Value |
-2.98 M | -787 K | -9.55 M | -8.14 M | -4.67 M | -4.24 M | -2.11 M | 625 K | 4.13 M | 6.44 M | 5.01 M | 2.05 M | 2.05 M | 2.05 M | 2.05 M | -881 K | -881 K | -881 K | -881 K | 2.41 M | 2.41 M | 2.41 M | 2.41 M | 12 M | 12 M | 12 M | 12 M | -67.7 M | -67.7 M | -67.7 M | -67.7 M | -53.8 M | -53.8 M | -53.8 M | -53.8 M | -29.8 M | -29.8 M | -29.8 M | -29.8 M | -4.01 M | -4.01 M | -4.01 M | -4.01 M | -1.41 M | -1.41 M | -1.41 M | -1.41 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M |
Total Shareholders Equity |
-3.27 M | -1.08 M | -9.55 M | -8.44 M | -4.67 M | -4.24 M | -2.11 M | -107 K | 4.13 M | 6.44 M | 5.01 M | 1.32 M | 1.32 M | 1.32 M | 1.32 M | -1.61 M | -1.61 M | -1.61 M | -1.61 M | 1.74 M | 1.74 M | 1.74 M | 1.74 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | -68.1 M | -68.1 M | -68.1 M | -68.1 M | -54.3 M | -54.3 M | -54.3 M | -54.3 M | -29.8 M | -29.8 M | -29.8 M | -29.8 M | -4.01 M | -4.01 M | -4.01 M | -4.01 M | -1.41 M | -1.41 M | -1.41 M | -1.41 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M |
All numbers in USD currency